1. Home
  2. MPAA vs TRDA Comparison

MPAA vs TRDA Comparison

Compare MPAA & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorcar Parts  of America Inc.

MPAA

Motorcar Parts of America Inc.

HOLD

Current Price

$11.50

Market Cap

253.7M

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$7.00

Market Cap

268.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPAA
TRDA
Founded
1968
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
253.7M
268.6M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
MPAA
TRDA
Price
$11.50
$7.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$17.50
$21.00
AVG Volume (30 Days)
117.4K
299.4K
Earning Date
06-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
162.63
N/A
EPS
N/A
N/A
Revenue
$789,806,000.00
$25,421,000.00
Revenue This Year
$1.50
$39.97
Revenue Next Year
$7.42
$50.80
P/E Ratio
N/A
N/A
Revenue Growth
4.28
N/A
52 Week Low
$9.29
$5.02
52 Week High
$18.12
$16.45

Technical Indicators

Market Signals
Indicator
MPAA
TRDA
Relative Strength Index (RSI) 31.52 49.66
Support Level $11.06 $5.71
Resistance Level $11.99 $7.95
Average True Range (ATR) 0.49 0.41
MACD -0.05 -0.03
Stochastic Oscillator 8.97 37.37

Price Performance

Historical Comparison
MPAA
TRDA

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts, test solutions, and diagnostic equipment. Its replacement parts are mainly sold to automotive retail chain stores, warehouse distributors across North America, and automobile manufacturers for aftermarket and warranty replacement programs. The Company's test solutions and diagnostic equipment serve the automotive component and powertrain testing market. Its product portfolio includes rotating electrical products such as alternators and starters; brake-related products including brake calipers, brake rotors, brake pads, brake master cylinders, and wheel hub assemblies and bearings; and other products. Its segments are Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: